Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Stomach Neoplasms 15Rectal Neoplasms 13Triple Negative Breast Neoplasms 10Pancreatic Neoplasms 7Neoplasm Metastasis 7Nasopharyngeal Carcinoma 6Colonic Neoplasms 6Neoplasms 4Gallbladder Neoplasms 4Cholangiocarcinoma 4Anus Neoplasms 4Adenocarcinoma Of Esophagus 4Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Somatostatinoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Klatskin Tumor 2Esophageal Squamous Cell Carcinoma 2Colorectal Cancer Metastatic 2Clinical Stage I Gastric Cancer AJCC v8 2Biliary Tract Neoplasms 2Adenoma, Islet Cell 2Squamous Cell Carcinoma of Head and Neck 1Spinocerebellar Degenerations 1Solid Cancer 1Skin Neoplasms 1Rectal Diseases 1

Interventions

encorafenib 1Oxaliplatin 1Levoleucovorin 1Leucovorin 1Irinotecan 1Fluorouracil 1Cetuximab 1Capecitabine 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Colonic Diseases × Capecitabine × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡